Brain cap trial: patients test electromagnetic wave device for Alzheimer's and Parkinson's
NCT ID NCT07222605
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a device called MemorEM, which is a cap that sends low-level electromagnetic waves to the head. The goal is to get feedback from 1,000 patients with neurological diseases like Alzheimer's or Parkinson's, and their caregivers, on how easy the device is to use. Researchers hope this feedback will help improve the device's design and explore whether it might help with symptoms in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MemorEM device (delivers 915MHz electromagnetic waves via a cap)
What this could lead to
If successful, this study could help improve the design of the MemorEM device and suggest ways to make it easier for patients to use, potentially leading to better symptom management in future trials.
What could go wrong
This is a very early pilot study focused on user feedback, not on proving the device works. The number of participants is small, and there is no control group, so any reported benefits may be due to chance or the placebo effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CareONE Concierge
Atlanta, Georgia, 30305, United States